208 related articles for article (PubMed ID: 12421594)
1. Catechol-O-methyltransferase inhibition protects against 3,4-dihydroxyphenylalanine (DOPA) toxicity in primary mesencephalic cultures: new insights into levodopa toxicity.
Blessing H; Bareiss M; Zettlmeisl H; Schwarz J; Storch A
Neurochem Int; 2003 Jan; 42(2):139-51. PubMed ID: 12421594
[TBL] [Abstract][Full Text] [Related]
2. Catechol-O-methyltransferase inhibition attenuates levodopa toxicity in mesencephalic dopamine neurons.
Storch A; Blessing H; Bareiss M; Jankowski S; Ling ZD; Carvey P; Schwarz J
Mol Pharmacol; 2000 Mar; 57(3):589-94. PubMed ID: 10692500
[TBL] [Abstract][Full Text] [Related]
3. COMT-dependent protection of dopaminergic neurons by methionine, dimethionine and S-adenosylmethionine (SAM) against L-dopa toxicity in vitro.
Werner P; Di Rocco A; Prikhojan A; Rempel N; Bottiglieri T; Bressman S; Yahr MD
Brain Res; 2001 Mar; 893(1-2):278-81. PubMed ID: 11223018
[TBL] [Abstract][Full Text] [Related]
4. Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants.
Pardo B; Mena MA; Casarejos MJ; Paíno CL; De Yébenes JG
Brain Res; 1995 Jun; 682(1-2):133-43. PubMed ID: 7552304
[TBL] [Abstract][Full Text] [Related]
5. 3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of L-DOPA.
Asanuma M; Miyazaki I
BMC Neurosci; 2016 Jul; 17(1):52. PubMed ID: 27456338
[TBL] [Abstract][Full Text] [Related]
6. Metabolic inhibition enhances selective toxicity of L-DOPA toward mesencephalic dopamine neurons in vitro.
Nakao N; Nakai K; Itakura T
Brain Res; 1997 Nov; 777(1-2):202-9. PubMed ID: 9449429
[TBL] [Abstract][Full Text] [Related]
7. Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40-7592.
Acquas E; Carboni E; de Ree RH; Da Prada M; Di Chiara G
J Neurochem; 1992 Jul; 59(1):326-30. PubMed ID: 1613509
[TBL] [Abstract][Full Text] [Related]
8. Comparison of neurotoxicity following repeated administration of l-dopa, d-dopa and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donors.
Alexander T; Sortwell CE; Sladek CD; Roth RH; Steece-Collier K
Cell Transplant; 1997; 6(3):309-15. PubMed ID: 9171163
[TBL] [Abstract][Full Text] [Related]
9. Effects of catechol-O-methyltransferase inhibitors and L-3,4-dihydroxyphenylalanine with or without carbidopa on extracellular dopamine in rat striatum.
Kaakkola S; Wurtman RJ
J Neurochem; 1993 Jan; 60(1):137-44. PubMed ID: 8417137
[TBL] [Abstract][Full Text] [Related]
10. Catechol-O-methyltransferase inhibition increases striatal L-dopa and dopamine: an in vivo study in rats.
Brannan T; Martínez-Tica J; Yahr MD
Neurology; 1992 Mar; 42(3 Pt 1):683-5. PubMed ID: 1549240
[TBL] [Abstract][Full Text] [Related]
11. Effects of peripheral and central catechol-O-methyltransferase inhibition on striatal extracellular levels of dopamine: a microdialysis study in freely moving rats.
Napolitano A; Bellini G; Borroni E; Zürcher G; Bonuccelli U
Parkinsonism Relat Disord; 2003 Jan; 9(3):145-50. PubMed ID: 12573869
[TBL] [Abstract][Full Text] [Related]
12. L-dopa upregulates the expression and activities of methionine adenosyl transferase and catechol-O-methyltransferase.
Zhao WQ; Latinwo L; Liu XX; Lee ES; Lamango N; Charlton CG
Exp Neurol; 2001 Sep; 171(1):127-38. PubMed ID: 11520127
[TBL] [Abstract][Full Text] [Related]
13. Glia conditioned medium protects fetal rat midbrain neurones in culture from L-DOPA toxicity.
Mena MA; Casarejos MJ; Carazo A; Paino CL; García de Yébenes J
Neuroreport; 1996 Jan; 7(2):441-5. PubMed ID: 8730801
[TBL] [Abstract][Full Text] [Related]
14. Effects of tolcapone, a novel catechol-O-methyltransferase inhibitor, on striatal metabolism of L-dopa and dopamine in rats.
Napolitano A; Zürcher G; Da Prada M
Eur J Pharmacol; 1995 Feb; 273(3):215-21. PubMed ID: 7737328
[TBL] [Abstract][Full Text] [Related]
15. Toxic and protective effects of L-dopa on mesencephalic cell cultures.
Mytilineou C; Han SK; Cohen G
J Neurochem; 1993 Oct; 61(4):1470-8. PubMed ID: 8376999
[TBL] [Abstract][Full Text] [Related]
16. Microdialysis with radiometric monitoring of L-[β-11C]DOPA to assess dopaminergic metabolism: effect of inhibitors of L-amino acid decarboxylase, monoamine oxidase, and catechol-O-methyltransferase on rat striatal dialysate.
Okada M; Nakao R; Hosoi R; Zhang MR; Fukumura T; Suzuki K; Inoue O
J Cereb Blood Flow Metab; 2011 Jan; 31(1):124-31. PubMed ID: 20407462
[TBL] [Abstract][Full Text] [Related]
17. BIA 3-202, a novel catechol-O-methyltransferase inhibitor, enhances the availability of L-DOPA to the brain and reduces its O-methylation.
Parada A; Loureiro AI; Vieira-Coelho MA; Hainzl D; Soares-da-Silva P
Eur J Pharmacol; 2001 May; 420(1):27-32. PubMed ID: 11412836
[TBL] [Abstract][Full Text] [Related]
18. Catechol-O-methyltransferase decreases levodopa toxicity in vitro.
Offen D; Panet H; Galili-Mosberg R; Melamed E
Clin Neuropharmacol; 2001; 24(1):27-30. PubMed ID: 11290879
[TBL] [Abstract][Full Text] [Related]
19. Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture.
Mena MA; Khan U; Togasaki DM; Sulzer D; Epstein CJ; Przedborski S
J Neurochem; 1997 Jul; 69(1):21-33. PubMed ID: 9202290
[TBL] [Abstract][Full Text] [Related]
20. Catechol-O-methyltransferase inhibition increases the uptake of 11C-3-(3,4-dihydroxyphenyl)-L-alanine in the rat pancreas.
Bergström M; Lu L; Marquez M; Moulder R; Jacobsson G; Ogren M; Eriksson B; Watanabe Y; Långström B
Scand J Gastroenterol; 1996 Dec; 31(12):1216-22. PubMed ID: 8976015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
